Stay updated on IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Sign up to get notified when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.

Latest updates to the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page
- Check7 days agoChange DetectedA sitewide NIH notice announces updates about the transition from “Artificial Intelligence” to “Super Intelligence.” The page itself continues to show a 403 Forbidden error instead of the study record.SummaryDifference1%

- Check13 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe study record area now displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

- Check41 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previously visible study content. This blocks access to the trial details and related information on the page, reflecting an access restriction at the site level.SummaryDifference18%

- Check63 days agoChange DetectedThe page shows a new Revision: v3.6.6 tag replacing the previous v3.6.5, indicating a software build update. This change affects only the page's version label and does not alter study information or navigation.SummaryDifference0.0%

Stay in the know with updates to IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.